A New Force in Alternate Site?

01 Sep 1995

Executive Summary

When Bergen Brunswig bought rival drug wholesaler Durr-Fillauer in an effort to shore up its coverage in the Southeast, it also got one of the country’s most respected alternate site medical/surgical supply dealers. Many in the industry expected Bergen to sell off Durr’s med/surg piece. But Bergen never did divest it, and with its recent acquisition of Colonial appears to be venturing even further into med/surg.

Already Registered? Sign in to continue reading.

New to In Vivo? Start a free trial today!

Table
View full table

Topics

ASK THE ANALYST
Email

Print
Bookmark
Share

Tags:

BioPharmaceutical Medical Device Business Strategies

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

IV000223

Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

IV000223

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.

A New Force in Alternate Site?

Executive Summary

Topics

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

Register

Ask The Analyst

Email Article

A New Force in Alternate Site?

Executive Summary

Topics

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

Register

Ask The Analyst

Email Article

Sign In To Set a Search Alert